Cargando…

Partial ORF1ab Gene Target Failure with Omicron BA.2.12.1

Mutations in the genome of SARS-CoV-2 can affect the performance of molecular diagnostic assays. In some cases, such as S-gene target failure, the impact can serve as a unique indicator of a particular SARS-CoV-2 variant and provide a method for rapid detection. Here, we describe partial ORF1ab gene...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodino, Kyle G., Peaper, David R., Kelly, Brendan J., Bushman, Frederic, Marques, Andrew, Adhikari, Hriju, Tu, Zheng Jin, Marrero Rolon, Rebecca, Westblade, Lars F., Green, Daniel A., Berry, Gregory J., Wu, Fann, Annavajhala, Medini K., Uhlemann, Anne-Catrin, Parikh, Bijal A., McMillen, Tracy, Jani, Krupa, Babady, N. Esther, Hahn, Anne M., Koch, Robert T., Grubaugh, Nathan D., Rhoads, Daniel D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9199403/
https://www.ncbi.nlm.nih.gov/pubmed/35582905
http://dx.doi.org/10.1128/jcm.00600-22
Descripción
Sumario:Mutations in the genome of SARS-CoV-2 can affect the performance of molecular diagnostic assays. In some cases, such as S-gene target failure, the impact can serve as a unique indicator of a particular SARS-CoV-2 variant and provide a method for rapid detection. Here, we describe partial ORF1ab gene target failure (pOGTF) on the cobas SARS-CoV-2 assays, defined by a ≥2-thermocycle delay in detection of the ORF1ab gene compared to that of the E-gene. We demonstrate that pOGTF is 98.6% sensitive and 99.9% specific for SARS-CoV-2 lineage BA.2.12.1, an emerging variant in the United States with spike L452Q and S704L mutations that may affect transmission, infectivity, and/or immune evasion. Increasing rates of pOGTF closely mirrored rates of BA.2.12.1 sequences uploaded to public databases, and, importantly, increasing local rates of pOGTF also mirrored increasing overall test positivity. Use of pOGTF as a proxy for BA.2.12.1 provides faster tracking of the variant than whole-genome sequencing and can benefit laboratories without sequencing capabilities.